Genome-wide association studies (GWAS) of lung cancer in Asian never-smoking women have previously identified six susceptibility loci associated with lung cancer risk. To further discover new susceptibility loci, we i...
Genome-wide association studies (GWAS) of lung cancer in Asian never-smoking women have previously identified six susceptibility loci associated with lung cancer risk. To further discover new susceptibility loci, we imputed data from four GWAS of Asian non-smoking female lung cancer (6877 cases and 6277 controls) using the 1000 Genomes Project (Phase 1 Release 3) data as the reference and genotyped additional samples (5878 cases and 7046 controls) for possible replication. In our meta-analysis, three new loci achieved genome-wide significance, marked by single nucleotide polymorphism (SNP) rs7741164 at 6p21.1 (per-allele odds ratio (OR) = 1.17; P = 5.8 × 10(-13)), rs72658409 at 9p21.3 (per-allele OR = 0.77; P = 1.41 × 10(-10)) and rs11610143 at 12q13.13 (per-allele OR = 0.89; P = 4.96 × 10(-9)). These findings identified new genetic susceptibility alleles for lung cancer in never-smoking women in Asia and merit follow-up to understand their biological underpinnings.
作者:
Goldspiel, BarryHoffman, James M.Griffith, Niesha L.Goodin, SusanDeChristoforo, RobertMontello, Capt M.ichaelChase, Judy L.Bartel, SylviaPatel, Jharana T.inaFISOPP
TN. Niesha L. Griffith MD. James M. Hoffman New Brunswick. Robert DeChristoforo NCI Cancer Trials Support Unit Bethesda. Judy L. Chase is Executive Director is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant MA. Jharana Tina Patel Pharm.D. BCPS BCOP FASHP Chief is Clinical Pharmacy Specialist Section Clinical Center Pharmacy Department National Institutes of Health Pharm.D. BCPS is Medication Outcomes and Safety Officer Pharmaceutical Sciences St. Jude Children's Research Hospital FASHP is Director of Pharmacy and Infusion Services Arthur G. James Cancer Hospital and Richard J. Solove Research Institute The Ohio State University Pharm.D. BCOP FASHP FCCP Affairs Rutgers Cancer Institute of New Jersey and Professor of Medicine Division of Medical Oncology Robert Wood Johnson Medical School FASHP Chief is Clinical Center Pharmacy Department National Institutes of Health. CAPT Michael Montello Pharm.D. M.B.A. Clinical Investigations Branch National Cancer Institute (NCI) Cancer Therapy Evaluation Program and Project Officer Pharm.D. FASHP Director is Clinical Pharmacy Services University of Texas M. D. Anderson Cancer Center M.P.H. is Director of Pharmacy and Clinical Support Services Dana-Farber Cancer Institute Pharm.D. is Quality Assurance Officer Clinical Center National Institutes of Health Houston. Sylvia Bartel Boston M.S United States FISOPP
TN. Niesha L. Griffith MD. James M. Hoffman New Brunswick. Robert DeChristoforo NCI Cancer Trials Support Unit Bethesda. Judy L. Chase is Executive Director is Associate Branch Chief for Clinical Trials Technology and Pharmacist Consultant MA. Jharana Tina Patel Pharm.D. BCPS BCOP FASHP Chief is Clinical Pharmacy Specialist Section Clinical Center Pharmacy Department National Institutes of Health Pharm.D. BCPS is Medication Outcomes and Safety Officer Pharmaceutical Sciences St. Jude Children's Research Hospital FASHP is Director of Pharmacy and Inf
O1 The metabolomics approach to autism: identification of biomarkers for early detection of autism spectrum disorder A. K. Srivastava, Y. Wang, R. Huang, C. Skinner, T. Thompson, L. Pollard, T. Wood, F. Luo, R. Steven...
详细信息
O1 The metabolomics approach to autism: identification of biomarkers for early detection of autism spectrum disorder A. K. Srivastava, Y. Wang, R. Huang, C. Skinner, T. Thompson, L. Pollard, T. Wood, F. Luo, R. Stevenson O2 Phenome-wide association study for smoking- and drinking-associated genes in 26,394 American women with African, Asian, European, and Hispanic descents R. Polimanti, J. Gelernter O3 Effects of prenatal environment, genotype and DNA methylation on birth weight and subsequent postnatal outcomes: findings from GUSTO, an Asian birth cohort X. Lin, I. Y. Lim, Y. Wu, A. L. Teh, L. Chen, I. M. Aris, S. E. Soh, M. T. Tint, J. L. MacIsaac, F. Yap, K. Kwek, S. M. Saw, M. S. Kobor, M. J. Meaney, K. M. Godfrey, Y. S. Chong, J. D. Holbrook, Y. S. Lee, P. D. Gluckman, N. Karnani, GUSTO study group O4 High-throughput identification of specific qt interval modulating enhancers at the SCN5A locus A. Kapoor, D. Lee, A. Chakravarti O5 Identification of extracellular matrix components inducing cancer cell migration in the supernatant of cultivated mesenchymal stem cells C. Maercker, F. Graf, M. Boutros O6 Single cell allele specific expression (ASE) IN T21 and common trisomies: a novel approach to understand DOWN syndrome and other aneuploidies G. Stamoulis, F. Santoni, P. Makrythanasis, A. Letourneau, M. Guipponi, N. Panousis, M. Garieri, P. Ribaux, E. Falconnet, C. Borel, S. E. Antonarakis O7 Role of microRNA in LCL to IPSC reprogramming S. Kumar, J. Curran, J. Blangero O8 Multiple enhancer variants disrupt gene regulatory network in Hirschsprung disease S. Chatterjee, A. Kapoor, J. Akiyama, D. Auer, C. Berrios, L. Pennacchio, A. Chakravarti O9 Metabolomic profiling for the diagnosis of neurometabolic disorders T. R. Donti, G. Cappuccio, M. Miller, P. Atwal, A. Kennedy, A. Cardon, C. Bacino, L. Emrick, J. Hertecant, F. Baumer, B. Porter, M. Bainbridge, P. Bonnen, B. Graham, R. Sutton, Q. Sun, S. Elsea O10 A novel causal methylation network approach to Alzheimer’s
作者:
Yong LeiHui ZhaoXiaogang GuoYun LiuYang CaoYi DengXiongfeng ChenHon Ki Christopher ChengIgor B.DawidYonglong ChenShenzhen Research Institute
The Chinese University of Hong Kong Shenzhen 518057 P.R.China Key Laboratory of Regenerative Biology Guangzhou Institutes of Biomedicine and HealthChinese Academy of Sciences Guangzhou 510530 P.R.China Department of Biology South University of Science and Technology of China Shenzhen 518055 P.R.China Advanced Biomedical Computing Center National Cancer Institute National Institutes of Health Frederick MD 21702 USA Program in Genomics of Differentiation The Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Bethesda MD 20892 USA School of Biomedical Sciences
Faculty of Medicine The Chinese University of Hong Kong Shatin New TerritoriesHong Kong P.R.China School of Biomedical Sciences Faculty of Medicine The Chinese University of Hong Kong Shatin New TerritoriesHong Kong P.R.China
Transcription activator-like effector nucleases (TALENs) are a novel approach for directed gene disruption and have been proved to be effective in various animal *** we report that TALENs can induce somatic mutations ...
Transcription activator-like effector nucleases (TALENs) are a novel approach for directed gene disruption and have been proved to be effective in various animal *** we report that TALENs can induce somatic mutations in Xenopus embryos with reliably high efficiency and that such mutations are heritable through germline *** modified the Golden Gate method for TALEN assembly to make the product suitable for RNA transcription and microinjection into Xenopus embryos.
暂无评论